Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Piet Ost
Profile
Projects
Publications
Activities
Awards & Distinctions
279
Results
2023
Accuracy and reliability of a commercial treatment planning system in nontarget regions in modern prostate radiotherapy
Willeke Danckaert
Piet Ost
Carlos De Wagter
A1
Journal Article
in
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS
2023
Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial
Mathieu Spaas
Nora Sundahl
Vibeke Kruse
Sylvie Rottey
Daan De Maeseneer
Fréderic Duprez
Yolande Lievens
Veerle Surmont
Lieve Brochez
Dries Reynders
et al.
A1
Journal Article
in
JAMA ONCOLOGY
2023
Clinical and genomic differences between advanced molecular imaging-detected and conventional imaging-detected metachronous oligometastatic castration-sensitive prostate cancer
Philip Sutera
Yang Song
Kim Van der Eecken
Amol C Shetty
Keara English
Theresa Hodges
Jinhee Chang
Valerie Fonteyne
Zaker Rana
Lei Ren
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2023
Cohort analysis to identify metastatic prostate cancer drivers
Louise de Schaetzen van Brienen
Kathleen Marchal
Piet Ost
Dissertation
2023
Evaluating the impact of prostate only versus pelvic radiotherapy for pathological node-positive prostate cancer : first results from the multicenter phase 3 PROPER trial
Valerie Fonteyne
Charles Van Praet
Piet Ost
Siska Van Bruwaene
Nick Liefhooghe
Charlien Berghen
Gert De Meerleer
Ben Vanneste
Caroline Verbaeys
Sofie Verbeke
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2023
Experiences of men with prostate cancer participating in a clinical pathway with a supervised group-based exercise program to combat androgen deprivation-induced side effects : a qualitative focus group study
Renée Bultijnck
Elke Rammant
Anneleen Raes
Nathalie Vandecasteele
Karel Decaestecker
Valerie Fonteyne
Nicolaas Lumen
Piet Ost
Benedicte Deforche
A1
Journal Article
in
SEMINARS IN ONCOLOGY NURSING
2023
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy : systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
Stephanie G C Kroeze
Matea Pavic
Karin Stellamans
Yolande Lievens
Carlotta Becherini
Marta Scorsetti
Filippo Alongi
Umberto Ricardi
Barbara Alicja Jereczek-Fossa
Paulien Westhoff
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2023
PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial
Piet Ost
Shankar Siva
Sigmund Brabrand
Piet Dirix
Nick Liefhooghe
François-Xavier Otte
Alfonso Gomez-Iturriaga
Wouter Everaerts
Mohamed Shelan
Antonio Conde-Moreno
et al.
U
Journal Article
in
EUROPEAN UROLOGY ONCOLOGY
2023
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer
P A Sutera
A C Shetty
A Hakansson
Karlien Van der Eecken
Y Song
Y Liu
J Chang
Valerie Fonteyne
A A Mendes
Nicolaas Lumen
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2023
WNT pathway mutations in metachronous oligometastatic castration-sensitive prostate cancer
Philip Sutera
Matthew P. Deek
Kim Van der Eecken
Amol C. Shetty
Jin Hee Chang
Theresa Hodges
Yang Song
Sofie Verbeke
Jo Van Dorpe
Valerie Fonteyne
et al.
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2023
Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer
Marija Pizurica
Maarten Larmuseau
Kim Van der Eecken
Louise de Schaetzen van Brienen
Francisco Carrillo-Perez
Simon Valentijn Isphording
Nicolaas Lumen
Jo Van Dorpe
Piet Ost
Sofie Verbeke
et al.
A1
Journal Article
in
CANCER RESEARCH
2023
2022
Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial
Valerie Fonteyne
P. Dirix
Charles Van Praet
C. Berghen
M. Albersen
S. Junius
N. Liefhooghe
L. Noé
G. De Meerleer
Piet Ost
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2022
Bone health and therapeutic agents in advanced prostate cancer
Maria Antonia Gómez-Aparicio
Fernando López-Campos
Lira Pelari-Mici
David Buchser
Jorge Pastor
Xavier Maldonado
Juan Zafra
Alison C. Tree
Renée Bultijnck
Paul Sargos
et al.
A1
Journal Article
in
FRONTIERS IN BIOSCIENCE-LANDMARK
2022
Detection and treatment of oligorecurrent prostate cancer : the next step towards cure
Aurélie De Bruycker
Piet Ost
Valerie Fonteyne
Dissertation
2022
Genomic features of lung-recurrent hormone-sensitive prostate cancer
Nicolette M. Fonseca
Kim Van der Eecken
Cameron Herberts
Sofie Verbeke
Sarah W.S. Ng
Nicolaas Lumen
Elie Ritch
Andrew J. Murtha
Cecily Q. Bernales
Elena Schönlau
et al.
A1
Journal Article
in
JCO PRECISION ONCOLOGY
2022
Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature
Willeke Danckaert
Mathieu Spaas
Katrien Vandecasteele
Carlos De Wagter
Piet Ost
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2022
Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials
MP Deek
K Van der Eecken
P Sutera
RA Deek
Valerie Fonteyne
AA Mendes
Karel Decaestecker
AP Kiess
Nicolaas Lumen
R Phillips
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2022
Multicentric prospective local treatment of metastatic prostate cancer (LoMP) study
Sarah Buelens
Filip Poelaert
Tom Claeys
Elise De Bleser
Bert Dhondt
Wesley Verla
Piet Ost
Bernard Rappe
Bart De Troyer
Caroline Verbaeys
et al.
A1
Journal Article
in
BJU INTERNATIONAL
2022
Optimizing rehabilitation interventions in men with prostate cancer receiving androgen deprivation therapy
Renée Bultijnck
Piet Ost
Benedicte Deforche
Dissertation
2022
PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer : acute toxicity
T. Zilli
S. Siva
R. Heikkila
P. Dirix
N. Liefhooghe
F. Otte
A. Gomez-Iturriaga
W. Everaerts
M. Shelan
A. Conde-Moreno
et al.
C3
Conference
2022
Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial
Jan Vanwelkenhuyzen
Mathieu Spaas
Kim Van der Eecken
Vibeke Kruse
Sylvie Rottey
Lieve Brochez
Johan Lindberg
Katleen De Preter
Bram De Laere
Piet Ost
C3
Conference
2022
Unraveling the genomic underpinnings of advanced prostate cancer
Kim Van der Eecken
Piet Ost
Jo Van Dorpe
Sofie Verbeke
Dissertation
2022
2021
Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : results of a phase 2 trial
Flor Verghote
P. Dirix
Charles Van Praet
C. Berghen
M. Albersen
S. Junius
N. Liefhooghe
M. Brosens
G. De Meerleer
Piet Ost
et al.
C3
Conference
2021
Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre
Cedric Peters
Julie Vandewiele
Yolande Lievens
Marc Van Eijkeren
Valerie Fonteyne
Tom Boterberg
Pieter Deseyne
Liv Veldeman
Wilfried De Neve
Christel Monten
et al.
A1
Journal Article
in
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY
2021
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial
Mathieu Spaas
Nora Sundahl
Eva Hulstaert
Vibeke Kruse
Sylvie Rottey
Daan De Maeseneer
Veerle Surmont
Annabel Meireson
Lieve Brochez
Dries Reynders
et al.
A1
Journal Article
in
BMC CANCER
2021
Clinical and genomic indolence in lung-recurrent metastatic hormone-sensitive prostate cancer
Nicolette Fonseca
Kim Van der Eecken
Cameron Herberts
Sofie Verbeke
Sarah Ng
Nicolaas Lumen
Elie Ritch
Andrew Murtha
Cecily Bernales
Elena Schönlau
et al.
C3
Conference
2021
Clinical relevance of serum Kyn/Trp ratio and basal and IFN gamma-upregulated IDO1 expression in peripheral monocytes in early stage melanoma
Annabel Meireson
Liesbeth Ferdinande
Marc Haspeslagh
Benjamin Hennart
Delphine Allorge
Piet Ost
Nora Sundahl
Mathieu Spaas
Annelies Demeyer
Lieve Brochez
A1
Journal Article
in
FRONTIERS IN IMMUNOLOGY
2021
Combined longitudinal clinical and autopsy phenomic assessment in lethal metastatic prostate cancer : recommendations for advancing precision medicine
Juho Jasu
Teemu Tolonen
Emmanuel S. Antonarakis
Himisha Beltran
Susan Halabi
Mario A. Eisenberger
Michael A. Carducci
Yohann Loriot
Kim Van der Eecken
Martijn Lolkema
et al.
A1
Journal Article
in
EUROPEAN UROLOGY OPEN SCIENCE
2021
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
Nicola Rares Franco
Michela Carlotta Massi
Francesca Ieva
Andrea Manzoni
Anna Maria Paganoni
Paolo Zunino
Liv Veldeman
Piet Ost
Valerie Fonteyne
Christopher J. Talbot
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2021
Emerging prognostic groups across the spectrum of metastatic castration-sensitive prostate cancer : disease outcomes and genomics
P. Sutera
Kim Van der Eecken
A.U. Kishan
A. Hamid
E. Grist
G. Attard
T.L. Lotan
A. Mendes
C. Sweeney
C. Paller
et al.
C3
Conference
2021
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial
Flor Verghote
Lindsay Poppe
Sofie Verbeke
Piet Dirix
Maarten Albersen
Gert De Meerleer
Charlien Berghen
Piet Ost
Geert Villeirs
Pieter De Visschere
et al.
A1
Journal Article
in
BMC CANCER
2021
Exercise prescription dose for castrate-resistant prostate cancer patients : a phase I prescription dose escalation trial
Renée Bultijnck
Benedicte Deforche
Noëmi Borrey
Jörgen Van Bauwel
Maarten Lievens
Elke Rammant
Valerie Fonteyne
Karel Decaestecker
Adelheid Steyaert
Nicolaas Lumen
et al.
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2021
Genetic testing in prostate cancer in clinical practice
Robin de Putter
Bram De Laere
Piet Ost
Kathleen Claes
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2021
Genomic features of lung-recurrent hormone sensitive prostate cancer
Kim Van der Eecken
Nicolette Fonseca
Cameron Herberts
Sofie Verbeke
Sarah Ng
Nicolaas Lumen
Elie Ritch
Andrew Murtha
Cecily Bernales
Elena Schönlau
et al.
C3
Conference
2021
Health-related quality of life in patients with advanced prostate cancer : a systematic review
Alexander Kretschmer
Guillaume Ploussard
Isabel Heidegger
Igor Tsaur
Hendrik Borgmann
Cristian Surcel
Romain Mathieu
Pieter De Visschere
Massimo Valerio
Roderick C.N. van den Bergh
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2021
Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures
Annabel Meireson
Simon Tavernier
Sofie Van Gassen
Nora Sundahl
Annelies Demeyer
Mathieu Spaas
Vibeke Kruse
Liesbeth Ferdinande
Jo Van Dorpe
Benjamin Hennart
et al.
A1
Journal Article
in
CANCERS
2021
Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial
Mathieu Spaas
Nora Sundahl
Sylvie Rottey
VIBEKE KRUSE
Daan De Maeseneer
Fréderic Duprez
Piet Dirix
Veerle Surmont
Yolande Lievens
Robin Van den Begin
et al.
C3
Conference
2021
Increased pathway complexity is a prognostic biomarker in metastatic castration-resistant prostate cancer
Bram De Laere
A Crippa
A Mortezavi
C Ghysel
P Rajan
M Eklund
A Wyatt
L Dirix
Piet Ost
H Grönberg
et al.
A1
Journal Article
in
CANCERS
2021
Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach
Kim Van der Eecken
Maarten Larmuseau
Jan Vanwelkenhuyzen
Nicolaas Lumen
Kathleen Marchal
Jo Van Dorpe
Piet Ost
Bram De Laere
Sofie Verbeke
C3
Conference
2021
Progression-directed therapy for oligoprogression in castration-refractory prostate cancer
Charlien Berghen
Steven Joniau
Piet Ost
Kenneth Poels
Wouter Everaerts
Karel Decaestecker
Karin Haustermans
Gaëtan Devos
Gert De Meerleer
A1
Journal Article
in
EUROPEAN UROLOGY ONCOLOGY
2021
Spatiotemporal evolution of radiation myositis on 18F-FDG PET/CT following hypofractionated radiotherapy of intramuscular melanoma metastases
Mathieu Spaas
Bliede Van den Broeck
David Creytens
Vibeke Kruse
Piet Ost
Editorial material
2021
The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases
Thomas Zilli
Piet Dirix
Reino Heikkila
Nick Liefhooghe
Shankar Siva
Alfonso Gomez-Iturriaga
Wouter Everaerts
Francois Otte
Mohamed Shelan
Carole Mercier
et al.
Editorial material
2021
The mutational landscape of metastatic castration-sensitive prostate cancer : the spectrum theory revisited
Matthew P. Deek
Kim Van der Eecken
Ryan Phillips
Neil R. Parikh
Pedro Isaacsson Velho
Tamara L. Lotan
Amar U. Kishan
Tobias Maurer
Paul C. Boutros
Christopher Hovens
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2021
The role of cytoreductive radical prostatectomy in the treatment of newly diagnosed low-volume metastatic prostate cancer : results from the local treatment of metastatic prostate cancer (LoMP) registry
Nicolaas Lumen
Elise De Bleser
Sarah Buelens
Wesley Verla
Filip Poelaert
Wietse Claeys
Valerie Fonteyne
Sofie Verbeke
Geert Villeirs
Kathia De Man
et al.
A1
Journal Article
in
EUROPEAN UROLOGY OPEN SCIENCE
2021
Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review
Kim Van der Eecken
Jan Vanwelkenhuyzen
Matthew P. Deek
Phuoc T. Tran
Evan Warner
Alexander W. Wyatt
Edmond M. Kwan
Sofie Verbeke
Jo Van Dorpe
Valerie Fonteyne
et al.
A1
Journal Article
in
EUROPEAN UROLOGY ONCOLOGY
2021
2020
A deep learning approach validates genetic risk factors for late toxicity after prostate cancer radiotherapy in a REQUITE Multi-National Cohort
Michela Carlotta Massi
Francesca Gasperoni
Francesca Ieva
Anna Maria Paganoni
Paolo Zunino
Andrea Manzoni
Nicola Rares Franco
Liv Veldeman
Piet Ost
Valerie Fonteyne
et al.
A1
Journal Article
in
FRONTIERS IN ONCOLOGY
2020
A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer
Elise De Bleser
Ruben Willems
Karel Decaestecker
Lieven Annemans
Aurélie De Bruycker
Valerie Fonteyne
Nicolaas Lumen
Filip Ameye
Ignace Billiet
Steven Joniau
et al.
A1
Journal Article
in
CANCERS
2020
Adoption of single-fraction radiotherapy for uncomplicated bone metastases in a tertiary centre
Cedric Peters
Julie Vandewiele
Yolande Lievens
Marc Van Eijkeren
Valerie Fonteyne
Tom Boterberg
Pieter Deseyne
Liv Veldeman
Wilfried De Neve
Christel Monten
et al.
C3
Conference
2020
Characterisation and classification of oligometastatic disease : a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Guckenberger
Yolande Lievens
Angelique B. Bouma
Laurence Collette
Andre Dekker
Nandita M. deSouza
Anne-Marie C. Dingemans
Beatrice Fournier
Coen Hurkmans
Frédéric E. Lecouvet
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2020
Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples
Louise de Schaetzen van Brienen
Maarten Larmuseau
Kim Van der Eecken
FREDERIC DE RYCK
Pauline Robbe Vandewalle
Anna Schuh
Jan Fostier
Piet Ost
Kathleen Marchal
A1
Journal Article
in
BMC MEDICAL GENOMICS
2020
Effect of extended pelvic lymph node dissection on oncologic outcomes in patients with D'Amico intermediate and high risk prostate cancer treated with radical prostatectomy : a multi-institutional study
Felix Preisser
Roderick C. N. van den Bergh
Giorgio Gandaglia
Piet Ost
Christian I. Surcel
Prasanna Sooriakumaran
Francesco Montorsi
Markus Graefen
Henk van der Poel
Alexandre de la Taille
et al.
A1
Journal Article
in
JOURNAL OF UROLOGY
2020
External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection
Giorgio Gandaglia
Alberto Martini
Guillaume Ploussard
Nicola Fossati
Armando Stabile
Pieter De Visschere
Hendrik Borgmann
Isabel Heidegger
Fabian Steinkohl
Alexander Kretschmer
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2020
Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer : an umbrella review
Elke Rammant
Lisa Van Wilder
Mieke Van Hemelrijck
Nele Pauwels
Karel Decaestecker
Charles Van Praet
Renée Bultijnck
Piet Ost
Thomas Van Vaerenbergh
Sofie Verhaeghe
et al.
A1
Journal Article
in
QUALITY OF LIFE RESEARCH
2020
Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy : systematic review of the recent literature
Lauren Villeirs
Thomas Tailly
Piet Ost
Marjan Waterloos
Karel Decaestecker
Valerie Fonteyne
Charles Van Praet
Nicolaas Lumen
A1
Journal Article
in
INTERNATIONAL JOURNAL OF UROLOGY
2020
Inferring the genomic landscape of lymph-node positive high-risk prostate cancer
Jan Vanwelkenhuyzen
Kim Van der Eecken
Bram De Laere
Simon Sundling
Rebecka Bergström
Johan Lindberg
Katleen De Preter
Henrik Grönberg
Piet Ost
C3
Conference
2020
Management of patients with advanced prostate cancer : report of the Advanced Prostate Cancer Consensus Conference 2019
Silke Gillessena
Gerhardt Attard
Tomasz M. Beer
Himisha Beltran
Anders Bjartell
Alberto Bossi
Alberto Briganti
Rob G. Bristow
Kim N. Chi
Noel Clarke
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2020
Nonsurgical salvage local therapies for radiorecurrent prostate cancer : a systematic review and meta-analysis
Gianluca Ingrosso
Carlotta Becherini
Andrea Lancia
Saverio Caini
Piet Ost
Giulio Francolini
Morten Hoyer
Marta Bottero
Alberto Bossi
Thomas Zilli
et al.
A1
Journal Article
in
EUROPEAN UROLOGY ONCOLOGY
2020
Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer
Sarah Piron
Kathia De Man
Vanessa Schelfhout
Nick Van Laeken
Ken Kersemans
Eric Achten
Filip De Vos
Piet Ost
A1
Journal Article
in
EJNMMI RESEARCH
2020
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : a study protocol for a randomized controlled phase II trial
Aurélie De Bruycker
An Spiessens
P. Dirix
N. Koutsouvelis
I. Semac
N. Liefhooghe
A. Gomez-Iturriaga
W. Everaerts
F. Otte
A. Papachristofilou
et al.
A1
Journal Article
in
BMC CANCER
2020
PEACE V : salvage treatment of oligorecurrent nodal prostate cancer metastases (STORM) : a study protocol for a randomized controlled phase II trial
Aurélie De Bruycker
An Spiessens
P. Dirix
N. Koutsouvelis
I. Semac
N. Liefhooghe
A. Gomez-Iturriaga
W. Everaerts
F. Otte
A. Papachristofilou
et al.
A1
Journal Article
in
BMC CANCER
2020
PET–CT for staging patients with muscle invasive bladder cancer : is it more than just a fancy tool?
Valerie Fonteyne
Kathia De Man
Karel Decaestecker
Pieter De Visschere
P. Dirix
G. De Meerleer
C. Berghen
Piet Ost
Geert Villeirs
A1
Journal Article
in
CLINICAL AND TRANSLATIONAL IMAGING
2020
Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy
Piet Dirix
Michiel Strijbos
Tom Van den Mooter
Nick Liefhooghe
Siska Van Bruwaene
Pieter Uvin
Christophe Ghysel
Dieter Ost
Peter Schatteman
Samuel Bral
et al.
A1
Journal Article
in
FUTURE ONCOLOGY
2020
Prostate cancer : ESMO clinical practice guidelines for diagnosis, treatment and follow-up
C. Parker
E. Castro
K. Fizazi
A. Heidenreich
Piet Ost
G. Procopio
B. Tombal
S. Gillessen
A1
Journal Article
in
ANNALS OF ONCOLOGY
2020
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer : a systematic review
Verane Achard
Marta Bottero
Michel Rouzaud
Andrea Lancia
Marta Scorsetti
Andrea Riccardo Filippi
Ciro Franzese
Barbara Alicja Jereczek-Fossa
Gianluca Ingrosso
Piet Ost
et al.
A1
Journal Article
in
ACTA ONCOLOGICA
2020
Radium-223 within the evolving treatment options for metastatic castration-resistant prostate cancer : recommendations from a European expert working group
Joe M. O'Sullivan
Joan Carles
Richard Cathomas
Alfonso Gomez-Iturriaga
Daniel Heinrich
Gero Kramer
Piet Ost
Inge van Oort
Bertrand Tombal
A1
Journal Article
in
EUROPEAN UROLOGY ONCOLOGY
2020
Reply to Pirus Ghadjar, Thomas Wiegel’s letter to the editor re : Elise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al. Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer : a multi-institutional analysis comparing the outcome, toxicity of stereotactic body radiotherapy, elective nodal radiotherapy. Eur Urol 2019;76:732–9
Elise De Bleser
Piet Ost
A1
Journal Article
in
EUROPEAN UROLOGY
2020
Shifting the paradigm towards local therapies for oligometastatic prostate cancer
Elise De Bleser
Piet Ost
Nicolaas Lumen
Dissertation
2020
The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report
Gillian Thomas
Elizabeth Eisenhauer
Robert G. Bristow
Cai Grau
Coen Hurkmans
Piet Ost
Matthias Guckenberger
Eric Deutsch
Denis Lacombe
Damien C. Weber
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2020
The ProBio trial : molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
Alessio Crippa
Bram De Laere
Andrea Discacciati
Berit Larsson
Jason T. Connor
Erin E. Gabriel
Camilla Thellenberg
Elin Janes
Gunilla Enblad
Anders Ullen
et al.
A1
Journal Article
in
TRIALS
2020
Tracking the origins of metastatic seeding in de novo metastatic prostate cancer
Kim Van der Eecken
Evan Warner
Nicolaas Lumen
Matti Annala
Andrew Murtha
Elena Schönlau
Nicolette Fonseca
Cameron Herberts
Jan Vanwelkenhuyzen
Wesley Verla
et al.
C3
Conference
2020
Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine
Bert Dhondt
Edward Geeurickx
Joeri Tulkens
Jan Van Deun
Glenn Vergauwen
Lien Lippens
Ilkka Miinalainen
Pekka Rappu
Jyrki Heino
Piet Ost
et al.
A1
Journal Article
in
JOURNAL OF EXTRACELLULAR VESICLES
2020
2019
A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)
Carole Mercier
Piet Dirix
Piet Ost
Charlotte Billiet
Ines Joye
Peter Vermeulen
Yolande Lievens
Dirk Verellen
A1
Journal Article
in
BMC CANCER
2019
Abiraterone and spironolactone in prostate cancer : a combination to avoid
Bert Dhondt
Sarah Buelens
Jeroen Van Besien
Matthias Beysens
Elise De Bleser
Piet Ost
Nicolaas Lumen
A1
Journal Article
in
ACTA CLINICA BELGICA
2019
Aggressive variants of prostate cancer : are we ready to apply specific treatment right now?
Igor Tsaur
Isabel Heidegger
Alexander Kretschmer
Hendrik Borgmann
Giorgio Gandaglia
Alberto Briganti
Pieter De Visschere
Romain Mathieu
Massimo Valerio
Roderick van den Bergh
et al.
A1
Journal Article
in
CANCER TREATMENT REVIEWS
2019
Androgen receptor burden and poor response to abiraterone or enzalutamide in TP53 wild-type metastatic castration-resistant prostate cancer
Bram De Laere
Prabhakar Rajan
Henrik Gronberg
Luc Dirix
Johan Lindberg
Markus Mayrhofer
Tom Whitington
Pieter-Jan van Dam
Peter Van Oyen
Christophe Ghysel
et al.
A1
Journal Article
in
JAMA ONCOLOGY
2019
Assessing the role and optimal duration of hormonal treatment in association with salvage radiation therapy after radical prostatectomy : results from a multi-institutional study
Nicola Fossati
Daniele Robesti
R. Jeffrey Karnes
Matteo Soligo
Stephen A. Boorjian
Alberto Bossi
Gabriele Coraggio
Nadia Di Muzio
Cesare Cozzarini
Barbara Noris Chiorda
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2019
Boosting anticancer immunity with radiotherapy
Nora Sundahl
Piet Ost
Vibeke Kruse
Karel Decaestecker
Dissertation
2019
Castration-resistant prostate cancer-free survival in the multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial
Sarah Buelens
Filip Poelaert
Elise De Bleser
Bert Dhondt
Wesley Verla
Piet Ost
B. Rappe
B. De Troyer
C. Verbaeys
B. Kimpe
et al.
C3
Conference
2019
Current insights in the management of high-risk prostate cancer : still more questions than answers
Valerie Fonteyne
Piet Ost
Editorial material
2019
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer : not ready for prime time
Bert Dhondt
Elise De Bleser
Tom Claeys
Sarah Buelens
Nicolaas Lumen
Jo Vandesompele
Anneleen Beckers
Valerie Fonteyne
Kim Van der Eecken
Aurélie De Bruycker
et al.
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2019
Exploration of the urinary proteome in the search for new biomarkers for prostate cancer : a promising role for extracellular vesicles
Bert Dhondt
Glenn Vergauwen
Jan Van Deun
Edward Geeurickx
Lien Lippens
Joeri Tulkens
lkka Miinalainen
Pekka Rappu
Jyrki Heino Oulu, Finland
Piet Ost
et al.
C3
Conference
2019
External beam radiotherapy only as an alternative for radical cystectomy in highly selected bladder cancer patients
Valérie Fonteyne
Tom Vercauteren
Nicolaas Lumen
Werner De Gersem
Bruno Speleers
Geert Villeirs
Piet Ost
Pieter De Visschere
Karel Decaestecker
A2
Journal Article
in
BIOMEDICAL JOURNAL OF SCIENTIFIC & TECHNICAL RESEARCH
2019
Has the PROPHECY of AR-V7 been fulfilled?
Bram De Laere
Piet Ost
Henrik Gronberg
Johan Lindberg
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2019
Hereditary prostate cancer : primetime for genetic testing?
Isabel Heidegger
Igor Tsaur
Hendrik Borgmann
Christian Surcel
Alexander Kretschmer
Romain Mathieu
Pieter De Visschere
Massimo Valerio
Roderick CN van den Bergh
Piet Ost
et al.
A1
Journal Article
in
CANCER TREATMENT REVIEWS
2019
Imaging modalities in synchronous oligometastatic prostate cancer
Jurgen J Futterer
Cristian Surcel
Roderick van den Bergh
Hendrik Borgmann
Alberto Briganti
Giorgio Gandaglia
Alexander Kretschmer
Piet Ost
Prasanna Sooriakumaran
Derya Tilki
et al.
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2019
Implementation of a lifestyle‐based clinical pathway in daily clinical practice in men undergoing androgen deprivation therapy for prostate cancer
Renée Bultijnck
Anniek Bruggeman
BARBARA VAN RUYMBEKE
Stefanie Mortier
Anneleen Raes
Elke Rammant
Martine De Muynck
Benedicte Deforche
Valerie Fonteyne
Karel Decaestecker
et al.
C3
Conference
2019
Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer
Sarah Buelens
Elise De Bleser
Bert Dhondt
Wesley Verla
Karel Decaestecker
Piet Ost
Valerie Fonteyne
Kathia De Man
CHLOE STANDAERT
Sylvie Rottey
et al.
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2019
Introducing a castrate resistant prostate cancer (CRPC) model care pathway in Belgian hospitals : towards national standardization?
Tijl Vermassen
Thierry Roumeguere
Yannick Neybuch
Lucien Hoekx
Irena Fele
Brieuc Sautois
Wouter Everaerts
Daan De Maeseneer
Frederic Lecouvet
Nicolaas Lumen
et al.
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2019
Metastasectomy for visceral and skeletal oligorecurrent prostate cancer
Antonino Battaglia
Gaetan Devos
Karel Decaestecker
Manuel Witters
Lisa Moris
Thomas Van den Broeck
Charlien Berghen
Wouter Everaerts
Maarten Albersen
Arman Tsaturyan
et al.
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer : a multicenter study
Luca Triggiani
Rosario Mazzola
Stefano Maria Magrini
Gianluca Ingrosso
Paolo Borghetti
Fabio Trippa
Andrea Lancia
Beatrice Detti
Giulio Francolini
Fabio Matrone
et al.
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2019
Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer : a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy
Elise De Bleser
Barbara Alicja Jereczek-Fossa
David Pasquier
Thomas Zilli
Nicholas Van As
Andrei Fodor
Piet Dirix
Alfonso Gomez-Iturriaga
Fabio Trippa
Shankar Siva
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2019
Nodal oligorecurrent prostate cancer : anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates
Aurélie De Bruycker
Elise De Bleser
Karel Decaestecker
Valerie Fonteyne
Nicolaas Lumen
Pieter De Visschere
Kathia De Man
Louke Delrue
Bieke Lambert
Piet Ost
A1
Journal Article
in
EUROPEAN UROLOGY
2019
Oligometastatic prostate cancer : the game is afoot
Andrea Lancia
Thomas Zilli
Verane Achard
Piet Dirix
Wouter Everaerts
Alfonso Gomez-Iturriaga
Gianluca Ingrosso
Nick Liefhooghe
Raymond Miralbell
Shankar Siva
et al.
A1
Journal Article
in
CANCER TREATMENT REVIEWS
2019
Oligorecurrent prostate cancer limited to lymph nodes : getting our ducks in a row
Andrei Fodor
Andrea Lancia
Francesco Ceci
Maria Picchio
Morten Hoyer
Barbara Alicja Jereczek-Fossa
Piet Ost
Paolo Castellucci
Elena Incerti
Nadia Di Muzio
et al.
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2019
Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT
Alfonso Gomez-Iturriaga
Francisco Casquero Ocio
Piet Ost
Iratxe Fernandez
Emilia Rodeno
Roberto Llarena
Jorge Garcia-Olaverri
Roberto Ortiz de Zarate
Jon Cacicedo
Alina Ahtamon
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER CARE
2019
Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial
Elke Rammant
Piet Ost
Martijn Swimberghe
Barbara Vanderstraeten
Nicolaas Lumen
Karel Decaestecker
Renée Bultijnck
Gert De Meerleer
Camille Sarrazyn
Roos Colman
et al.
A1
Journal Article
in
STRAHLENTHERAPIE UND ONKOLOGIE
2019
Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and oncological outcomes
Andries Van Huele
Filip Poelaert
Valerie Fonteyne
Karel Decaestecker
Piet Ost
Nicolaas Lumen
A1
Journal Article
in
ACTA CHIRURGICA BELGICA
2019
Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma
Nora Sundahl
Teofila Seremet
Jo Van Dorpe
Bart Neyns
Liesbeth Ferdinande
Annabel Meireson
Lieve Brochez
Vibeke Kruse
Piet Ost
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2019
Positive pre-biopsy MRI : are systematic biopsies still useful in addition to targeted biopsies?
Guillaume Ploussard
Hendrik Borgmann
Alberto Briganti
Pieter De Visschere
Jurgen J Fütterer
Giorgio Gandaglia
Isabel Heidegger
Alexander Kretschmer
Romain Mathieu
Piet Ost
et al.
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2019
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
Petra Seibold
Adam Webb
Miguel E. Aguado-Barrera
David Azria
Celine Bourgier
Muriel Brengues
Erik Briers
Renée Bultijnck
Patricia Calvo-Crespo
Ana Carballo
et al.
A1
Journal Article
in
Radiotherapy and Oncology
2019
Radiation dosimetry and biodistribution of 18F-PSMA-11 for PET imaging of prostate cancer
Sarah Piron
Kathia De Man
Nick Van Laeken
Yves D'Asseler
Klaus Bacher
Ken Kersemans
Piet Ost
Karel Decaestecker
Pieter Deseyne
Valerie Fonteyne
et al.
A1
Journal Article
in
JOURNAL OF NUCLEAR MEDICINE
2019
Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results
Piet Ost
Nora Sundahl
G Vandekerkhove
Karel Decaestecker
Annabel Meireson
Pieter De Visschere
Valerie Fonteyne
Daan De Maeseneer
Dries Reynders
Els Goetghebeur
et al.
C3
Conference
2019
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma
Nora Sundahl
Gillian Vandekerkhove
Karel Decaestecker
Annabel Meireson
Pieter De Visschere
Valerie Fonteyne
Daan De Maeseneer
Dries Reynders
Els Goetghebeur
Jo Van Dorpe
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2019
Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results
Gillian Vandekerkhove
Nora Sundahl
Karel Decaestecker
Annabel Meireson
Pieter De Visschere
Valerie Fonteyne
Daan De Maeseneer
Dries Reynders
Els Goetghebeur
Jo Van Dorpe
et al.
C3
Conference
2019
Re: Gaetan Devos, Gert De Meerleer, Steven Joniau. Have we entered the era of imaging before salvage treatment for recurrent prostate cancer? Eur Urol 2019;76:265-7
Aurélie De Bruycker
Valerie Fonteyne
Piet Ost
A1
Journal Article
in
EUROPEAN UROLOGY
2019
Re: [Lu-177]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial) : a single-centre, single-arm, phase 2 study
Kathia De Man
Piet Ost
Editorial material
2019
Readressing the rationale of irradiation in stage I seminoma guidelines : a critical essay
Charlien Berghen
Maarten Albersen
Pierre Blanchard
Alberto Bossi
Alberto Briganti
Cesare Cozzarini
Karel Decaestecker
Valerie Fonteyne
Karin Haustermans
Steven Joniau
et al.
A1
Journal Article
in
BJU INTERNATIONAL
2019
Salvage lymph node dissection for nodal recurrent prostate cancer : a systematic review
Guillaume Ploussard
Giorgio Gandaglia
Hendrik Borgmann
Pieter De Visschere
Isabel Heidegger
Alexander Kretschmer
Romain Mathieu
Cristian Surcel
Derya Tilki
Igor Tsaur
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2019
Standard of care versus metastases-directed therapy for PET-detected nodal oligorecurrent prostate cancer following multimodality treatment : a multi-institutional case-control study
Thomas Steuber
Cordula Jilg
Pierre Tennstedt
Aurélie De Bruycker
D. Tilki
Karel Decaestecker
T. Zilli
Barbara Alicja Jereczek-Fossa
Ulrich Wetterauer
Anca-Ligia Grosu
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2019
TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer
Bram De Laere
Steffi Oeyen
Markus Mayrhofer
Tom Whitington
Pieter-Jan van Dam
Peter Van Oyen
Christophe Ghysel
Jozef Ampe
Piet Ost
Wim Demey
et al.
A1
Journal Article
in
CLINICAL CANCER RESEARCH
2019
The case against the European Medicines Agency's change to the label for radium-223 for the treatment of metastatic castration-resistant prostate cancer
Joe M. O'Sullivan
Daniel Heinrich
Nicholas D. James
Sten Nilsson
Piet Ost
Christopher C. Parker
Bertrand Tombal
A1
Journal Article
in
EUROPEAN UROLOGY
2019
Trends in management of oligometastatic hormone-sensitive prostate cancer
Gargi Kothari
Piet Ost
Patrick Cheung
Pierre Blanchard
Alison C. Tree
Nicholas J. van As
Simon S. Lo
Drew Moghanaki
Andrew Loblaw
Shankar Siva
A1
Journal Article
in
CURRENT ONCOLOGY REPORTS
2019
Trends in radical prostatectomy risk group distribution in a European multicenter analysis of 28 572 patients : towards tailored treatment
Roderick van den Bergh
Giorgio Gandaglia
Derya Tilki
Hendrik Borgmann
Piet Ost
Christian Surcel
Massimo Valerio
Prasanna Sooriakumaran
Laurent Salomon
Alberto Briganti
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2019
Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy : a qualitative interview study
Elke Rammant
Valerie Fonteyne
Karel Decaestecker
Renée Bultijnck
Benedicte Deforche
Ronny Pieters
Piet Ost
Sofie Verhaeghe
Ann Van Hecke
A1
Journal Article
in
CLINICAL REHABILITATION
2019
What is oligometastatic prostate cancer?
Michael Fraser
Bridget Koontz
Urban Emmenegger
Gert De Meerleer
Vincent Khoo
Felix Feng
Niall M. Corcoran
Christopher M. Hovens
Phuoc T. Tran
Piet Ost
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2019
2018
4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial
Valerie Fonteyne
Camille Sarrazyn
Martijn Swimberghe
Gert De Meerleer
Elke Rammant
Barbara Vanderstraeten
FRANK VANPACHTENBEKE
Nicolaas Lumen
Karel Decaestecker
Roos Colman
et al.
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2018
A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy
Elke Rammant
Karel Decaestecker
Renée Bultijnck
Nora Sundahl
Piet Ost
Nele Pauwels
Benedicte Deforche
Ronny Pieters
Valerie Fonteyne
A1
Journal Article
in
CLINICAL REHABILITATION
2018
AR-V7 predicting treatment response in metastasized prostate cancer : has it peaked?
Igor Tsaur
Hendrik Borgmann
Christian I. Surcel
Piet Ost
Guillaume Ploussard
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2018
Are clinical guidelines designed according to guidelines? Cross-sectional assessment of quality and transparency of clinical guidelines in urology
Roderick C. N. van den Bergh
Piet Ost
Christian Surcel
Massimo Valerio
Jurgen J. Futterer
Giorgio Gandaglia
Prasanna Sooriakumaran
Derya Tilki
Igor Tsaur
Guillaume Ploussard
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2018
Availability of prostate cancer exercise rehabilitation resources and practice patterns in Belgium : results of a cross-sectional study
Renée Bultijnck
BARBARA VAN RUYMBEKE
Sofie Everaert
Helena Bagué
Elke Rammant
Steven Rimbaut
Valerie Fonteyne
Nicolaas Lumen
Karel Decaestecker
Piet Ost
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER CARE
2018
Benefits of elective para-aortic radiotherapy for pN1 prostate cancer using arc therapy (intensity-modulated or volumetric modulated arc therapy) : protocol for a nonrandomized phase II trial
Cedric Draulans
Steven Joniau
Valerie Fonteyne
Louke Delrue
Karel Decaestecker
Wouter Everaerts
Piet Dirix
Laura Van den Bergh
Wouter Crijns
Hans Vandendriessche
et al.
A2
Journal Article
in
JMIR RESEARCH PROTOCOLS
2018
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
Markus Mayrhofer
Bram De Laere
Tom Whitington
Peter Van Oyen
Christophe Ghysel
Jozef Ampe
Piet Ost
Wim Demey
Lucien Hoekx
Dirk Schrijvers
et al.
A1
Journal Article
in
GENOME MEDICINE
2018
Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
Lieve Brochez
Annabel Meireson
Ines Chevolet
Nora Sundahl
Piet Ost
Vibeke Kruse
A1
Journal Article
in
NATURE COMMUNICATIONS
2018
Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer
Bram De Laere
Steffi Oeyen
Peter Van Oyen
Christophe Ghysel
Jozef Ampe
Piet Ost
Wim Demey
Lucien Hoekx
Dirk Schrijvers
Barbara Brouwers
et al.
A1
Journal Article
in
PROSTATE
2018
Clinical pathway improves implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects in men with prostate cancer
Renée Bultijnck
Inge Van de Caveye
Elke Rammant
Sofie Everaert
Nicolaas Lumen
Karel Decaestecker
Valerie Fonteyne
Benedicte Deforche
Piet Ost
A1
Journal Article
in
BJU INTERNATIONAL
2018
Combining anticancer drugs with osteoprotective agents in prostate cancer : a contemporary update
Igor Tsaur
Isabel Heidegger
Alexander Kretschmer
Hendrik Borgmann
Cristian Mirvald
Giorgio Gandaglia
Alberto Briganti
Roderick van den Bergh
Derya Tilki
Piet Ost
et al.
A1
Journal Article
in
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
2018
Consensus on molecular imaging and theranostics in prostate cancer
Stefano Fanti
Silvia Minozzi
Gerald Antoch
Ian Banks
Alberto Briganti
Ignasi Carrio
Arturo Chiti
Noel Clarke
Matthias Eiber
Johann De Bono
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2018
Curative treatment for muscle invasive bladder cancer in elderly patients : a systematic review
Valerie Fonteyne
Piet Ost
Joaquim Bellmunt
Jean Pierre Droz
Pierre Mongiat-Artus
Brant Inman
Elena Paillaud
Fred Saad
Guillaume Ploussard
A1
Journal Article
in
EUROPEAN UROLOGY
2018
Detecting long non-coding RNA biomarkers in prostate cancer liquid biopsies : hype or hope?
Hetty Helsmoortel
Celine Everaert
Nicolaas Lumen
Piet Ost
Jo Vandesompele
A2
Journal Article
in
NON-CODING RNA RESEARCH
2018
Effects of radiation on the metastatic process
Nora Sundahl
Fréderic Duprez
Piet Ost
Wilfried De Neve
Marcus Mareel
A1
Journal Article
in
MOLECULAR MEDICINE
2018
Endothelial indoleamine 2,3-dioxygenase is correlated with microsatellite status in colorectal carcinoma and predicts worse prognosis
Annabel Meireson
Ines Chevolet
Eva Hulstaert
Liesbeth Ferdinande
Piet Ost
Karen Geboes
Marc De Man
Dirk Van de Putte
Laurine Verset
Vibeke Kruse
et al.
C3
Conference
2018
Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium
Valerie Fonteyne
Elke Rammant
Piet Ost
Yolande Lievens
Bart De Troyer
Sylvie Rottey
Gert De Meerleer
Daan De Maeseneer
Dirk De Ridder
Karel Decaestecker
A1
Journal Article
in
CLINICAL GENITOURINARY CANCER
2018
Evaluation and preliminary radiation dosimetry of [18F]PSMA-11 for PET imaging of prostate cancer
Sarah Piron
Kathia De Man
Nick Van Laeken
Yves D'Asseler
Ken Kersemans
Piet Ost
Karel Decaestecker
Pieter Deseyne
Valerie Fonteyne
Nicolaas Lumen
et al.
C3
Conference
2018
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Tokhir Dadaev
Edward J. Saunders
Paul J. Newcombe
Ezequiel Anokian
Daniel A. Leongamornlert
Mark N. Brook
Clara Cieza-Borrella
Martina Mijuskovic
Sarah Wakerell
Ali Amin Al Olama
et al.
A1
Journal Article
in
NATURE COMMUNICATIONS
2018
Focal therapy in localised prostate cancer : real-world urological perspective explored in a cross-sectional European survey
Giancarlo Marra
Guillaume Ploussard
Piet Ost
Pieter De Visschere
Alberto Briganti
Giorgio Gandaglia
Derya Tilki
Christian I Surcel
Igor Tsaur
Roderick CN. Van Den Bergh
et al.
A1
Journal Article
in
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
2018
Four- or 5-weeks of radiotherapy for prostate cancer : interim results of a randomized phase 3 trial
Valerie Fonteyne
Martijn Swimberghe
Elke Rammant
Gert De Meerleer
Barbara Vanderstraeten
FRANK VANPACHTENBEKE
Nicolaas Lumen
Karel Decaestecker
Piet Ost
C3
Conference
2018
How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator
Giorgio Gandaglia
Roderick C. N. van den Bergh
Derya Tilki
Nicola Fossati
Piet Ost
Christian I. Surcel
Prasanna Sooriakumaran
Igor Tsaur
Massimo Valerio
Alexander Kretschmer
et al.
A1
Journal Article
in
BJU INTERNATIONAL
2018
Impact of early salvage radiation therapy in patients with persistently elevated or rising prostate-specific antigen after radical prostatectomy
Nicola Fossati
R. Jeffrey Karnes
Michele Colicchia
Stephen A. Boorjian
Alberto Bossi
Thomas Seisen
Nadia Di Muzio
Cesare Cozzarini
Barbara Noris Chiorda
Claudio Fiorino
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2018
Management of patients with advanced prostate cancer : the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Silke Gillessen
Gerhardt Attard
Tomasz M Beer
Himisha Beltran
Alberto Bossi
Rob Bristow
Brett Carver
Daniel Castellano
Byung Ha Chung
Noel Clarke
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2018
Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial
Sarah Buelens
Filip Poelaert
Bert Dhondt
Valerie Fonteyne
Pieter De Visschere
Piet Ost
Sofie Verbeke
Geert Villeirs
Kathia De Man
Sylvie Rottey
et al.
A1
Journal Article
in
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
2018
More extensive lymph node dissection at radical prostatectomy is associated with improved outcomes with salvage radiotherapy for rising prostate-specific antigen after surgery : a long-term, multi-institutional analysis
Nicola Fossati
William P. Parker
R. Jeffrey Karnes
Michele Colicchia
Alberto Bossi
Thomas Seisen
Nadia Di Muzio
Cesare Cozzarini
Barbara Noris Chiorda
Claudio Fiorino
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2018
Multicentric prospective local treatment of metastatic prostate cancer (LOMP) trial : interim analysis of clinical outcomes and prognostic factors
Sarah Buelens
Filip Poelaert
Bert Dhondt
Elise De Bleser
CAROLINE VERBAEYS
Bernard Rappe
Bart Kimpe
Ignace Billiet
Hendrik Plancke
Karen Fransis
et al.
C3
Conference
2018
Multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial : interim analysis of clinical outcomes and prognostic factors
Sarah Buelens
Filip Poelaert
Bert Dhondt
Elise De Bleser
Tom Claeys
CAROLINE VERBAEYS
Bernard Rappe
Bart Kimpe
Ignace Billiet
Hendrik Plancke
et al.
C3
Conference
2018
Multicentrische prospectieve Lokale behandeling van Metastatische Prostaatkanker (LoMP) studie : interim analyse van de klinische uitkomsten en prognostische factoren
Sarah Buelens
Filip Poelaert
Bert Dhondt
Elise De Bleser
Tom Claeys
CAROLINE VERBAEYS
Bernard Rappe
Bart Kimpe
Ignace Billiet
Hendrik Plancke
et al.
C3
Conference
2018
Open surgery versus primary radiotherapy in T4b sinonasal carcinoma
Jens Debacker
Wouter Huvenne
Katrien Bonte
Wilfried De Neve
Philippe Deron
Piet Ost
Thibaut Van Zele
Hubert Vermeersch
Fréderic Duprez
A1
Journal Article
in
B-ENT
2018
Patient-reported outcomes in the search for the optimal radiotherapy schedule for prostate cancer
Elke Rammant
Piet Ost
Martijn Swimberghe
FRANK VANPACHTENBEKE
Renée Bultijnck
Nicolaas Lumen
Karel Decaestecker
Valerie Fonteyne
C3
Conference
2018
Pembrolizumab for the treatment of bladder cancer
Nora Sundahl
Sylvie Rottey
Daan De Maeseneer
Piet Ost
A1
Journal Article
in
EXPERT REVIEW OF ANTICANCER THERAPY
2018
Peritumoral endothelial indoleamine 2,3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile
Annabel Meireson
Ines Chevolet
Eva Hulstaert
Liesbeth Ferdinande
Piet Ost
Karen Geboes
Marc De Man
Dirk Van de Putte
Laurine Verset
Vibeke Kruse
et al.
A2
Journal Article
in
ONCOTARGET
2018
Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma
Nora Sundahl
Katrien De Wolf
Vibeke Kruse
Annabel Meireson
Dries Reynders
Els Goetghebeur
Mireille Van Gele
Reinhart Speeckaert
Benjamin Hennart
Lieve Brochez
et al.
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2018
Prognostic and therapeutic implications of circulating androgen receptor gene copy number in prostate cancer patients using droplet digital polymerase chain reaction
Sarah Buelens
Tom Claeys
Bert Dhondt
Filip Poelaert
Matthijs Vynck
Nurten Yigit
Olivier Thas
Piet Ost
Jo Vandesompele
Nicolaas Lumen
et al.
A1
Journal Article
in
CLINICAL GENITOURINARY CANCER
2018
Prognostische significantie van metastatische symptomen bij nieuw gediagnosticeerd prostaatkanker
Elise De Bleser
Sarah Buelens
Bert Dhondt
CAROLINE VERBAEYS
Bernard Rappe
Bart Kimpe
Ignace Billiet
Hendrik Plancke
Karen Francis
Patrick Willemen
et al.
C3
Conference
2018
Prostate cancer-specific PET radiotracers : a review on the clinical utility in recurrent disease
Jaden D. Evans
Krishan R. Jethwa
Piet Ost
Scott Williams
Eugene D. Kwon
Val J. Lowe
Brian J. Davis
A1
Journal Article
in
PRACTICAL RADIATION ONCOLOGY
2018
Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al
Piet Ost
Dries Reynders
Karel Decaestecker
Valerie Fonteyne
Nicolaas Lumen
Bieke Lambert
Louke Delrue
Gert De Meerleer
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2018
Stereotactic body radiotherapy for primary prostate cancer
Gargi Kothari
Andrew Loblaw
Alison C. Tree
Nicholas J. van As
Drew Moghanaki
Simon S. Lo
Piet Ost
Shankar Siva
A1
Journal Article
in
TECHNOLOGY IN CANCER RESEARCH & TREATMENT
2018
Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial
Piet Ost
Dries Reynders
Karel Decaestecker
Valerie Fonteyne
Nicolaas Lumen
Aurélie De Bruycker
Bieke Lambert
Louke Delrue
Renée Bultijnck
Tom Claeys
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2018
Use of concomitant androgen deprivation therapy in patients treated with early salvage radiotherapy for biochemical recurrence after radical prostatectomy : long-term results from a large, multi-institutional series
Giorgio Gandaglia
Nicola Fossati
R. Jeffrey Karnes
Stephen A. Boorjian
Michele Colicchia
Alberto Bossi
Thomas Seisen
Cesare Cozzarini
Nadia Di Muzio
Barbara Noris Chiorda
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2018
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging Group
Frederic E Lecouvet
Daniela E Oprea-Lager
Yan Liu
Piet Ost
Luc Bidaut
Laurence Collette
Christophe M Deroose
Karolien Goffin
Ken Herrmann
Otto S Hoekstra
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2018
2017
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response
Nora Sundahl
Katrien De Wolf
Sylvie Rottey
Karel Decaestecker
Daan De Maeseneer
Annabel Meireson
Els Goetghebeur
Valerie Fonteyne
Sofie Verbeke
Pieter De Visschere
et al.
A1
Journal Article
in
JOURNAL OF TRANSLATIONAL MEDICINE
2017
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response
Katrien De Wolf
VIBEKE KRUSE
Nora Sundahl
Mireille Van Gele
Ines Chevolet
Reinhart Speeckaert
Lieve Brochez
Piet Ost
A1
Journal Article
in
JOURNAL OF TRANSLATIONAL MEDICINE
2017
Adjuvant and salvage radiotherapy after radical prostatectomy in prostate cancer patients
Giorgio Gandaglia
Alberto Briganti
Noel Clarke
R. Jeffrey Karnes
Markus Graefen
Piet Ost
Anthony Laurence Zietman
Mack Roach
A1
Journal Article
in
EUROPEAN UROLOGY
2017
Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : a phase II trial
Valerie Fonteyne
Piet Dirix
Sara Junius
Elke Rammant
Piet Ost
Gert De Meerleer
Martijn Swimberghe
Karel Decaestecker
A1
Journal Article
in
BMC CANCER
2017
Androgen receptor gene copy number and protein expression in treatment-naïve prostate cancer
Filip Poelaert
Candy Kumps
Nicolaas Lumen
Stéphanie Verschuere
Louis Libbrecht
Marleen Praet
Sylvie Rottey
Tom Claeys
Piet Ost
Karel Decaestecker
et al.
A1
Journal Article
in
UROLOGIA INTERNATIONALIS
2017
Androgen receptor gene copy number detection using droplet digital PCR and its therapeutic consequences in prostate cancer patients
Sarah Buelens
Tom Claeys
Candy Kumps
Bert Dhondt
Filip Poelaert
Nurten Yigit
Matthijs Vynck
Olivier Thas
Piet Ost
Jo Vandesompele
et al.
C3
Conference
2017
Bijwerkingen van 'immune checkpoint' inhibitoren : waar dient een huisarts alert op te zijn?
S De Keukeleire
Tessa Kerre
Piet Ost
Barbara De Moerloose
Karim Vermaelen
Lieve Brochez
Vibeke Kruse
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2017
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial
Katrien De Wolf
Sylvie Rottey
Karim Vermaelen
Karel Decaestecker
Nora Sundahl
Lizzy De Lobel
Els Goetghebeur
Gert De Meerleer
Nicolaas Lumen
Valerie Fonteyne
et al.
A1
Journal Article
in
RADIATION ONCOLOGY
2017
Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA
Pieter De Visschere
Nicolaas Lumen
Piet Ost
Karel Decaestecker
EVA PATTYN
Geert Villeirs
A1
Journal Article
in
CLINICAL RADIOLOGY
2017
Editorial comment
Filip Poelaert
Piet Ost
Nicolaas Lumen
Editorial material
2017
Exploring all avenues for radiotherapy in oligorecurrent prostate cancer disease limited to lymph nodes : a systematic review of the role of stereotactic body radiotherapy
Elisabetta Ponti
Andrea Lancia
Piet Ost
Fabio Trippa
Luca Triggiani
Beatrice Detti
Gianluca Ingrosso
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2017
Importance and outcome relevance of central pathology review in prostatectomy specimens : data from the SAKK 09/10 randomized trial on prostate cancer
Pirus Ghadjar
Stefanie Hayoz
Vera Genitsch
Daniel R Zwahlen
Tobias Hölscher
Philipp Gut
Matthias Guckenberger
Guido Hildebrandt
Arndt-Christian Müller
Paul M Putora
et al.
A1
Journal Article
in
BJU INTERNATIONAL
2017
Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing the definitions of CHAARTED and LATITUDE trial
Sarah Buelens
Karel Decaestecker
Valerie Fonteyne
Piet Ost
Sofie Verbeke
Geert Villeirs
Sylvie Rottey
Nicolaas Lumen
C3
Conference
2017
Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and therapeutic effect
Andries Van Huele
Filip Poelaert
Valerie Fonteyne
Karel Decaestecker
Piet Ost
Sarah Buelens
Nicolaas Lumen
C3
Conference
2017
Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy
Aurélie De Bruycker
Bieke Lambert
Tom Claeys
Louke Delrue
Chamberlain Mbah
Gert De Meerleer
Geert Villeirs
Filip De Vos
Kathia De Man
Karel Decaestecker
et al.
A1
Journal Article
in
BJU INTERNATIONAL
2017
Prospective comparison of F-18 choline PET/CT scan versus axial MRI for detecting bone metastasis in biochemically relapsed prostate cancer patients
Wouter Huysse
Frederic Lecouvet
Paolo Castellucci
Piet Ost
VALERIE LAMBRECHT
Carlos Artigas
Marie-Laurence Denis
Kathia De Man
Louke Delrue
Lennart Jans
et al.
A1
Journal Article
in
DIAGNOSTICS
2017
Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer
Elise De Bleser
Phuoc T. Tran
Piet Ost
A1
Journal Article
in
CURRENT OPINION IN UROLOGY
2017
Re: Declan G. Murphy, Christopher J. Sweeney, Bertrand Tombal. 'Gotta catch 'em all' or do we? Pokemet approach to metastatic prostate cancer. Eur Urol 2017;72:1–3
Alison C Tree
Shankar Siva
Piet Ost
A1
Journal Article
in
EUROPEAN UROLOGY
2017
Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer : a systematic review protocol
Elke Rammant
Renée Bultijnck
Nora Sundahl
Piet Ost
Nele Pauwels
Benedicte Deforche
Ronny Pieters
Karel Decaestecker
Valerie Fonteyne
A2
Journal Article
in
BMJ OPEN
2017
Salvage stereotactic body radiotherapy for isolated lymph node recurrent prostate cancer : single institution series of 94 consecutive patients and 124 lymph nodes
Barbara Alicja Jereczek-Fossa
Giuseppe Fanetti
Cristiana Fodor
Delia Ciardo
Luigi Santoro
Claudia Maria Francia
Matteo Muto
Alessia Surgo
Dario Zerini
Giulia Marvaso
et al.
A1
Journal Article
in
CLINICAL GENITOURINARY CANCER
2017
The ION-Ghent guidelines for the management of immune related adverse events (irAE's)
Vibeke Kruse
Max Schreuer
Karim Vermaelen
Piet Ost
Tessa Kerre
Barbara De Moerloose
Lieve Brochez
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2017
The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma : prognostic features in the era of targeted therapies
Tom Claeys
Nicolaas Lumen
Candy Kumps
Marleen Praet
Gert De Meerleer
Sylvie Rottey
Piet Ost
Pieter De Visschere
Geert Villeirs
Valerie Fonteyne
et al.
A1
Journal Article
in
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
2017
The occurrence and therapeutic consequences of androgen receptor copy number gain in prostate cancer patients using Droplet Digital PCR
Sarah Buelens
Tom Claeys
Candy Kumps
Bert Dhondt
Filip Poelaert
Y Nurten
Matthijs Vynck
Olivier Thas
Piet Ost
Jo Vandesompele
et al.
C3
Conference
2017
Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (18F-FDG-PET) in the treatment of bone metastases : results from a 3-arm randomized phase II trial
Dieter Berwouts
Katrien De Wolf
Wilfried De Neve
Ana Maria Luiza Olteanu
Bieke Lambert
Bruno Speleers
Ingeborg Goethals
Indira Madani
Piet Ost
A1
Journal Article
in
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY
2017
Whole pelvis radiotherapy for pathological node-positive prostate cancer
Filip Poelaert
Valerie Fonteyne
Piet Ost
Bart De Troyer
Karel Decaestecker
Gert De Meerleer
Pieter De Visschere
Tom Claeys
Bert Dhondt
Nicolaas Lumen
A1
Journal Article
in
STRAHLENTHERAPIE UND ONKOLOGIE
2017
mRNA capture sequencing enabled liquid biopsy screening
Anneleen Decock
Olivier De Wever
Bert Dhondt
Carolina Fierro
An Hendrix
Hetty Helsmoortel
Scott Kuersten
Pieter Mestdagh
Nele Nijs
Piet Ost
et al.
C3
Conference
2017
2016
Combinatie van een hoge dosis externe radiotherapie met een simultaan geïntegreerde boost op de dominante intraprostatische lesie : analyse van de genito-urnaire en rectale toxiciteit
Nora Sundahl
Gert De Meerleer
Geert Villeirs
Piet Ost
Wilfried De Neve
Nicolaas Lumen
Pieter De Visschere
Marc Van Eijkeren
Valérie Fonteyne
Newsarticle
2016
Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion : analysis of genito-urinary and rectal toxicity
Nora Sundahl
Gert De Meerleer
Geert Villeirs
Piet Ost
Wilfried De Neve
Nicolaas Lumen
Pieter De Visschere
Marc Van Eijkeren
Valérie Fonteyne
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2016
Comparison of the ACR and ESUR PIRADSv1 and v2 in a cohort of 245 patients with histopathological and/or long term follow up
Pieter De Visschere
EVA PATTYN
Piet Ost
Tom Claeys
Geert Villeirs
C3
Conference
2016
Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) version 1 and 2 in a cohort of 245 patients with histopathological reference and long-term follow-up
Pieter De Visschere
EVA PATTYN
Piet Ost
Tom Claeys
Nicolaas Lumen
Geert Villeirs
A1
Journal Article
in
JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY
2016
Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients
Christian Nicolaj Andreassen
Barry S Rosenstein
Sarah L Kerns
Harry Ostrer
Dirk De Ruysscher
Jamie A Cesaretti
Gillian C Barnett
Alison M Dunning
Leila Dorling
Catharine ML West
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2016
Pattern of progression after stereotactic body radiotherapy for oligometastatic prostate cancer nodal recurrences
Piet Ost
BA Jereczek-Fossa
N Van As
T Zilli
A Tree
D Henderson
R Orecchia
F Casamassima
A Surgo
R Miralbell
et al.
A1
Journal Article
in
CLINICAL ONCOLOGY
2016
Practice patterns compared with evidence-based strategies for the management of androgen deprivation therapy-induced side effects in prostate cancer patients : results of a European web-based survey
Renée Bultijnck
Cristian Surcel
Guillaume Ploussard
Alberto Briganti
Pieter De Visschere
Jurgen Fütterer
Pirus Ghadjar
Gianluca Giannarini
Hendrik Isbarn
Christophe Massard
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2016
Progression-free survival following stereotactic body radiotherapy for oligometastatic prostate cancer treatment-naive recurrence : a multi-institutional analysis
Piet Ost
Barbara Alicja Jereczek-Fossa
Nicholas Van As
Thomas Zilli
Alexander Muacevic
Kenneth Olivier
Daniel Henderson
Franco Casamassima
Roberto Orecchia
Alessia Surgo
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2016
Re: Christopher JD Wallis, Refik Saskin, Richard Choo, et al. Surgery versus radiotherapy for clinically-localized prostate cancer : a systematic review and meta-analysis. Eur Urol 2016;70:21-30
Piet Ost
Pirus Ghadjar
A1
Journal Article
in
EUROPEAN UROLOGY
2016
Reply from authors re: Vincent Khoo. Is there another bite of the cherry? The case for radical local therapy for oligometastatic disease in prostate cancer. Eur Urol 2016;69:13-4 Oligometastatic prostate cancer: more than just cherry-picking?
Barbara Alicja Jereczek-Fossa
Piet Ost
Gert De Meerleer
Editorial material
2016
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer
Pieter De Visschere
Alberto Briganti
Jurgen Fütterer
Pirus Ghadjar
Hendrik Isbarn
Christophe Massard
Piet Ost
Prasanna Sooriakumaran
Cristian Surcel
Massimo Valerio
et al.
A2
Journal Article
in
INSIGHTS INTO IMAGING
2016
The outcome for patients with pathologic node-positive prostate cancer treated with intensity modulated radiation therapy and androgen deprivation therapy: a case-matched analysis of pN1 and pN0 patients
Annelies Van Hemelryk
Gert De Meerleer
Piet Ost
Filip Poelaert
Werner De Gersem
Karel Decaestecker
Pieter De Visschere
Valérie Fonteyne
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2016
Whole pelvis intensity-modulated arc therapy for lymph node metastasized prostate cancer: oncologic outcomes and prognostic factors
Filip Poelaert
Valérie Fonteyne
Tom Claeys
Piet Ost
Karel Decaestecker
Gert De Meerleer
Bert Dhondt
Pieter De Visschere
Nicolaas Lumen
C3
Conference
2016
2015
Acute toxicity and early quality of life after dose intensified salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10
Pirus Ghadjar
Tobias Hoelscher
Philipp Gut
Matthias Guckenberger
Guido Hildebrandt
Arndt-Christian Mueller
Ludwig Plasswilm
Alexandros Papachristofilou
Stefanie Hayoz
Marcin Sumila
et al.
C3
Conference
2015
Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy : first results of the randomized trial SAKK 09/10
Pirus Ghadjar
Stefanie Hayoz
Jürg Bernhard
Daniel R Zwahlen
Tobias Hölscher
Philipp Gut
Matthias Guckenberger
Guido Hildebrandt
Arndt-Christian Müller
Ludwig Plasswilm
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2015
Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: a 3-arm randomized phase II trial
Dieter Berwouts
Katrien De Wolf
Bieke Lambert
Renée Bultijnck
Wilfried De Neve
Lizzy De Lobel
Lennart Jans
Els Goetghebeur
Bruno Speleers
Ana Maria Luiza Olteanu
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2015
Can we expand active surveillance criteria to include biopsy Gleason 3 + 4 prostate cancer? A multi-institutional study of 2,323 patients
Guillaume Ploussard
Hendrik Isbarn
Alberto Briganti
Prasanna Sooriakumaran
Christian I. Surcel
Laurent Salomon
Massimo Freschi
Cristian Mirvald
Henk G. van der Poel
Anna Jenkins
et al.
A1
Journal Article
in
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
2015
Clinical perspectives from randomized phase 3 trials on prostate cancer : an analysis of the ClinicalTrials.gov database
Alexandros Tsikkinis
Nikola Cihoric
Gianluca Giannarini
Stefan Hinz
Alberto Briganti
Peter Wust
Piet Ost
Guillaume Ploussard
Christophe Massard
Cristian I. Surcel
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2015
Cognitive factors influencing treatment decision-making in patients with localised prostate cancer : development of a standardised questionnaire
Julie Devos
Charles Van Praet
Karel Decaestecker
Tom Claeys
Valérie Fonteyne
Veerle Decalf
Gert De Meerleer
Piet Ost
Nicolaas Lumen
A1
Journal Article
in
ACTA CLINICA BELGICA
2015
Evaluation of the effect of cytoreductive nephrectomy on the course of metastatic renal cell carcinoma: a single centre study
Tom Claeys
Nicolaas Lumen
Gilles Thuysbaert
Marleen Praet
Gert De Meerleer
Sylvie Rottey
Piet Ost
Pieter De Visschere
Geert Villeirs
Valérie Fonteyne
et al.
C3
Conference
2015
How bad is the outcome of node positive prostate cancer patients: a matched case analysis between N+ and N0 prostate cancer patients
Valérie Fonteyne
Annelies Van Hemelryk
Nicolaas Lumen
Piet Ost
Karel Decaestecker
Pieter De Visschere
Gert De Meerleer
C3
Conference
2015
Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer : a 10-years single centre experience
Valérie Fonteyne
SIMIN SADEGHI
Piet Ost
FRANK VANPACHTENBEKE
PHILIPPE VUYE
Nicolaas Lumen
Gert De Meerleer
A1
Journal Article
in
ACTA ONCOLOGICA
2015
Management of node only recurrence after primary local treatment for prostate cancer : a systematic review of the literature
Guillaume Ploussard
Christophe Almeras
Alberto Briganti
Gianluca Giannarini
Christophe Hennequin
Piet Ost
Raphaële Renard-Penna
Ambroise Salin
Thierry Lebret
Arnauld Villers
et al.
A1
Journal Article
in
JOURNAL OF UROLOGY
2015
Metastasis-directed therapy for oligometastatic prostate cancer recurrence
Karel Decaestecker
Nicolaas Lumen
Piet Ost
Dissertation
2015
Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature
Piet Ost
Alberto Bossi
Karel Decaestecker
Gert De Meerleer
Gianluca Giannarini
R Jeffrey Karnes
Mack, III Roach
Alberto Briganti
A1
Journal Article
in
EUROPEAN UROLOGY
2015
Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect
Katrien De Wolf
Piet Ost
VIBEKE KRUSE
Lieve Brochez
Ines Chevolet
C3
Conference
2015
Preferences for the management of androgen deprivation-induced osteoporosis and metabolic syndrome in prostate cancer patients: A European web-based survey
Renée Bultijnck
Christian Surcel
Guillaume Ploussard
Alberto Briganti
Pieter De Visschere
Jurgen Fütterer
Pirus Ghadjar
Gianluca Giannarini
Hendrik Isbarn
Christophe Massard
et al.
C3
Conference
2015
Preferences in management of high-risk prostate cancer among urologists in Europe: results of a web-based survey
Cristian I Surcel
Prasanna Sooriakumaran
Alberto Briganti
Pieter De Visschere
Jurgen J Fütterer
Pirus Ghadjar
Hendrik Isbarn
Piet Ost
Guillaume Ploussard
Roderick CN van den Bergh
et al.
A1
Journal Article
in
BJU INTERNATIONAL
2015
Prognostic effect of neuroendocrine differentiation in prostate cancer : a critical review
Cristian I Surcel
Inge M van Oort
Prasanna Sooriakumaran
Alberto Briganti
Pieter De Visschere
Jurgen J Fütterer
Pirus Ghadjar
Henrik Isbarn
Piet Ost
Roderick CN van den Bergh
et al.
A1
Journal Article
in
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
2015
Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome
Tom Claeys
Charles Van Praet
Nicolaas Lumen
Piet Ost
Valérie Fonteyne
Gert De Meerleer
Bieke Lambert
Louke Delrue
Pieter De Visschere
Geert Villeirs
et al.
A1
Journal Article
in
BIOMED RESEARCH INTERNATIONAL
2015
Systematic ultrasound-guided saturation and template biopsy of the prostate : indications and advantages of extended sampling
Henrik Isbarn
Alberto Briganti
Pieter De Visschere
Jurgen J Fütterer
Pirus Ghadjar
Gianluca Giannarini
Piet Ost
Guillaume Ploussard
Prasanna Sooriakumaran
Christian I Surcel
et al.
A1
Journal Article
in
ARCHIVOS ESPANOLES DE UROLOGIA
2015
The oncologic role of local treatment in primary metastatic prostate cancer
Pirus Ghadjar
Alberto Briganti
Pieter De Visschere
Jurgen J Fütterer
Gianluca Giannarini
Henrik Isbarn
Piet Ost
Prasanna Sooriakumaran
Christian I Surcel
Roderick CN Van den Bergh
et al.
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2015
The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy
Katrien De Wolf
Karim Vermaelen
Gert De Meerleer
Bart Lambrecht
Piet Ost
A1
Journal Article
in
ONCOIMMUNOLOGY
2015
The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study
Filip Poelaert
Charles Van Praet
ANNE-SOPHIE BEERENS
Gert De Meerleer
Valérie Fonteyne
Piet Ost
Nicolaas Lumen
A1
Journal Article
in
BIOMED RESEARCH INTERNATIONAL
2015
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? : results from a multi-institutional series
Giorgio Gandaglia
Guillaume Ploussard
Henrik Isbarn
Nazareno Suardi
Pieter De Visschere
Jurgen J Fütterer
Pirus Ghadjar
Christophe Massard
Piet Ost
Prasanna Sooriakumaran
et al.
A1
Journal Article
in
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
2015
2014
Comparison of fluor-18 choline PET/CT versus MRI for detecting bone metastasis in relapsed prostate cancer
Bieke Lambert
Wouter Huysse
Louke Delrue
Kathia De Man
Ingeborg Goethals
Gert De Meerleer
Filip De Vos
Karel Decaestecker
Piet Ost
C3
Conference
2014
Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complications
Charles Van Praet
Karel Decaestecker
Valérie Fonteyne
Piet Ost
Pieter De Visschere
Stephanie Verschuere
Sylvie Rottey
Nicolaas Lumen
A1
Journal Article
in
INTERNATIONAL JOURNAL OF UROLOGY
2014
Hair-sparing whole brain radiotherapy with volumetric arc therapy in patients treated for brain metastases: dosimetric and clinical results of a phase II trial
Annemieke De Puysseleyr
Joris Van de Velde
Bruno Speleers
Tom Vercauteren
Anneleen Goedgebeur
Tom Van Hoof
Tom Boterberg
Wilfried De Neve
Carlos De Wagter
Piet Ost
A1
Journal Article
in
RADIATION ONCOLOGY
2014
Integrated models for the prediction of late genitourinary complaints after high-dose intensity modulated radiotherapy for prostate cancer: making informed decisions
Sofie De Langhe
Gert De Meerleer
Kim De Ruyck
Piet Ost
Valérie Fonteyne
Wilfried De Neve
Hubert Thierens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2014
Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients
Houssein El Saghire
Charlot Vandevoorde
Piet Ost
Pieter Monsieurs
Arlette Michaux
Gert De Meerleer
Sarah Baatout
Hubert Thierens
A1
Journal Article
in
INTERNATIONAL JOURNAL OF ONCOLOGY
2014
Multiparametrische prostaat-MRI: klinische toepassingen
Pieter De Visschere
Willem Oosterlinck
Gert De Meerleer
Karel Decaestecker
Valérie Fonteyne
Nicolaas Lumen
Piet Ost
Geert Villeirs
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2014
Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer
Piet Ost
Karel Decaestecker
Bieke Lambert
Valérie Fonteyne
Louke Delrue
Nicolaas Lumen
Filip Ameye
Gert De Meerleer
A1
Journal Article
in
PROSTATE
2014
Radiotherapy for renal-cell carcinoma
Gert De Meerleer
Vincent Khoo
Bernard Escudier
Steven Joniau
Alberto Bossi
Piet Ost
Alberto Briganti
Valérie Fonteyne
Marco Van Vulpen
Nicolaas Lumen
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2014
Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol 2014;65:1058–66
Piet Ost
Alberto Briganti
Gianluca Giannarini
A1
Journal Article
in
EUROPEAN UROLOGY
2014
Rectal toxicity after intensity modulated radiotherapy for prostate cancer: which rectal dose volume constraints should we use?
Valérie Fonteyne
Piet Ost
FRANK VANPACHTENBEKE
Roos Colman
SIMIN SADEGHI
Geert Villeirs
Karel Decaestecker
Gert De Meerleer
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2014
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Karel Decaestecker
Gert De Meerleer
Bieke Lambert
Louke Delrue
Valérie Fonteyne
Tom Claeys
Filip De Vos
Wouter Huysse
Arne Hautekiet
Gaethan Maes
et al.
A1
Journal Article
in
RADIATION ONCOLOGY
2014
Salvage pelvic lymph node dissection in prostate cancer: surgical and oncological outcome
Tom Claeys
Charles Van Praet
Karel Decaestecker
Piet Ost
Valérie Fonteyne
Gert De Meerleer
Pieter De Visschere
Geert Villeirs
Nicolaas Lumen
C3
Conference
2014
Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial
Karel Decaestecker
Gert De Meerleer
Filip Ameye
Valérie Fonteyne
Bieke Lambert
Steven Joniau
Louke Delrue
Ignace Billiet
Wim Duthoy
Sarah Junius
et al.
A1
Journal Article
in
BMC CANCER
2014
To prospectively compare F18-choline PET/CT and axial skeleton MRI for the detection of bone metastases in patients with biochemically recurrent prostate cancer (PCa)
Piet Ost
Wouter Huysse
Louke Delrue
Karel Decaestecker
Gert De Meerleer
Filip De Vos
Valérie Fonteyne
Bieke Lambert
C3
Conference
2014
What kind of high-grade prostate cancers do we miss with multiparametric magnetic resonance imaging?
Pieter De Visschere
Leslie Naesens
Louis Libbrecht
Charles Van Praet
Nicolaas Lumen
Piet Ost
Valérie Fonteyne
Karel Decaestecker
EVA PATTYN
Geert Villeirs
C3
Conference
2014
2013
Acute and late toxicity after postoperative high-dose pelvic radiotherapy and androgen deprivation for node positive prostate cancer patients: a powerful tool that should be handled with care?
Charles Van Praet
Nicolaas Lumen
Gert De Meerleer
Piet Ost
Katrien Vandecasteele
Geert Villeirs
Karel Decaestecker
Valérie Fonteyne
C3
Conference
2013
Acute radiation-induced nocturia in prostate cancer patients is associated with pretreatment symptoms, radical prostatectomy, and genetic markers in the TGFβ1 gene
Sofie De Langhe
Kim De Ruyck
Piet Ost
Valérie Fonteyne
Joke Werbrouck
Gert De Meerleer
Wilfried De Neve
Hubert Thierens
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2013
Development of a new highly specific targeting probe for non-invasive in vivo visualization of Ncadherin expression in prostate cancer
Christian Vanhove
Caroline Dumolyn
Piet Ost
Olivier De Wever
Filip De Vos
C3
Conference
2013
Developments in external beam radiotherapy for prostate cancer
Nicolaas Lumen
Piet Ost
Charles Van Praet
Gert De Meerleer
Geert Villeirs
Valérie Fonteyne
A1
Journal Article
in
UROLOGY
2013
Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT
Joke Werbrouck
Piet Ost
Valérie Fonteyne
Gert De Meerleer
Wilfried De Neve
Evelien Bogaert
Laurence Beels
Klaus Bacher
Anne Vral
Hubert Thierens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2013
Feasibility study of a Hadron Therapy Centre in Belgium
Lieven Annemans
Francis Colardyn
Roger De Croock
Wilfried De Neve
Fréderic Duprez
Akos Gulyban
Kris Henau
Yolande Lievens
Indira Madani
Piet Ost
et al.
Report
2013
High-dose intensity-modulated arc radiotherapy for lymph node metastasized prostate cancer: toxicity and early clinical outcome
Valérie Fonteyne
Nicolaas Lumen
Charles Van Praet
Piet Ost
Karel Decaestecker
Gert De Meerleer
C3
Conference
2013
Hypofractionated frameless stereotactic intensity-modulated radiotherapy with whole brain radiotherapy for the treatment of 1-3 brain metastases
BRUNO DE POTTER
Gert De Meerleer
Wilfried De Neve
Tom Boterberg
Bruno Speleers
Piet Ost
A1
Journal Article
in
NEUROLOGICAL SCIENCES
2013
Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcome
Valérie Fonteyne
Nicolaas Lumen
Piet Ost
Charles Van Praet
Katrien Vandecasteele
Werner De Gersem
Geert Villeirs
Wilfried De Neve
Karel Decaestecker
Gert De Meerleer
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2013
Imaging treated prostate cancer
Pieter De Visschere
HA Vargas
Piet Ost
Gert De Meerleer
Geert Villeirs
A1
Journal Article
in
ABDOMINAL IMAGING
2013
Management of locally recurrent disease
Piet Ost
Valérie Fonteyne
Pieter De Visschere
Nicolaas Lumen
Gert De Meerleer
Bookchapter
in
Prostate cancer : a comprehensive perspective
2013
Metastasis-directed therapy for oligmetastic prostate recurrence
Karel Decaestecker
Gert De Meerleer
Louke Delrue
Bieke Lambert
Valérie Fonteyne
Nicolaas Lumen
Charles Van Praet
PATRICK BERKOVIC
Geert Villeirs
Pieter De Visschere
et al.
C3
Conference
2013
Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy
Charles Van Praet
Piet Ost
Nicolaas Lumen
Gert De Meerleer
Katrien Vandecasteele
Geert Villeirs
Karel Decaestecker
Valérie Fonteyne
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2013
Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy
PATRICK BERKOVIC
Gert De Meerleer
Louke Delrue
Bieke Lambert
Valérie Fonteyne
Nicolaas Lumen
Karel Decaestecker
Geert Villeirs
PHILIPPE VUYE
Piet Ost
A1
Journal Article
in
CLINICAL GENITOURINARY CANCER
2013
The importance of the number of metastases on prostate cancer-specific survival in patients with noncastrate metastatic prostate cancer following curative treatment
Piet Ost
Karel Decaestecker
Bieke Lambert
Valérie Fonteyne
Louke Delrue
Nicolaas Lumen
Gert De Meerleer
C3
Conference
2013
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer : results of the Quality Assurance Program of the Randomized Trial SAKK 09/10
Manfred Sassowsky
Philipp Gut
Tobias Hölscher
Guido Hildebrandt
Arndt-Christian Müller
Yousef Najafi
Götz Kohler
Helmut Kranzbühler
Matthias Guckenberger
Daniel R. Zwahlen
et al.
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2013
2012
An immobilized antibody targeting N-cadherin facilitates spread of N-cadherin-positive tumour cells
Danielle Maes
Marc Bracke
Piet Ost
A1
Journal Article
in
ANTICANCER RESEARCH
2012
Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancer
Valérie Fonteyne
Nicolaas Lumen
Geert Villeirs
Piet Ost
Gert De Meerleer
A2
Journal Article
in
ADVANCES IN UROLOGY
2012
Detection, localisation and exclusion of high grade prostate cancer with multiparametric MRI: correlation with radical prostatectomy histopathology
Pieter De Visschere
ALEXANDRA DE POTTER
Gert De Meerleer
Nicolaas Lumen
Valérie Fonteyne
Piet Ost
Willem Oosterlinck
Geert Villeirs
C3
Conference
2012
Evaluation of the efficacy and safety of Salvia officinalis in controlling hot flashes in prostate cancer patients treated with androgen deprivation
Katrien Vandecasteele
Piet Ost
Willem Oosterlinck
Valérie Fonteyne
Wilfried De Neve
Gert De Meerleer
A1
Journal Article
in
PHYTOTHERAPY RESEARCH
2012
High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapy
Piet Ost
Cesare Cozzarini
Gert De Meerleer
Claudio Fiorino
BRUNO DE POTTER
Alberto Briganti
Evi Nagler
Francesco Montorsi
Valérie Fonteyne
Nadia De Muzio
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2012
Improving positioning in high-dose radiotherapy for prostate cancer: safety and visibility of frequently used gold fiducial markers
Valérie Fonteyne
Piet Ost
Geert Villeirs
Willem Oosterlinck
ALINE IMPENS
Werner De Gersem
Carlos De Wagter
Gert De Meerleer
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2012
Limited versus extended pelvic lymph node dissection in prostate cancer patients
Charles Van Praet
Heleen Maes
Valérie Fonteyne
Karel Decaestecker
Geert Villeirs
Piet Ost
Gert De Meerleer
Nicolaas Lumen
C3
Conference
2012
Population screening for prostate cancer: an overview of available studies and meta-analysis
Nicolaas Lumen
Valérie Fonteyne
Gert De Meerleer
Piet Ost
Geert Villeirs
Alexandre Mottrie
Pieter De Visschere
BART DE TROYER
Willem Oosterlinck
A1
Journal Article
in
INTERNATIONAL JOURNAL OF UROLOGY
2012
Prostate MRI at 3.0T versus endorectal 1.5T: comparison of spectral and overall image quality
Pieter De Visschere
Gert De Meerleer
Karel Decaestecker
Piet Ost
Geert Villeirs
C3
Conference
2012
Salvage radiotherapy : a plea for dose-escalation with intensity-modulated radiotherapy
Piet Ost
Cesare Cozzarini
Alberto Bossi
Gert De Meerleer
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2012
Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy
PATRICK BERKOVIC
Gert De Meerleer
Louke Delrue
Bieke Lambert
Valérie Fonteyne
Nicolaas Lumen
Karel Decaestecker
Geert Villeirs
PHILIPPE VUYE
Piet Ost
C3
Conference
2012
Screening and early diagnosis of prostate cancer: an update
Nicolaas Lumen
Valérie Fonteyne
Gert De Meerleer
Pieter De Visschere
Piet Ost
Willem Oosterlinck
Geert Villeirs
A1
Journal Article
in
ACTA CLINICA BELGICA
2012
Surgical outcome of robot-assisted radical prostatectomy after a training program in a high-volume robotic centre
Charles Van Praet
Nicolaas Lumen
BART DE TROYER
Valérie Fonteyne
Karel Decaestecker
Gert De Meerleer
Willem Oosterlinck
Piet Ost
Alexandre Mottrie
C3
Conference
2012
Whole abdominopelvic radiotherapy (WAPRT) using intensity modulated arc therapy (IMAT) as palliation for chemotherapy-resistant ovarian cancer
Katrien Vandecasteele
Amin Makar
Philippe Tummers
Hannelore Denys
Rudy Van den Broecke
Louke Delrue
Pieter De Visschere
Piet Ost
Gert De Meerleer
C3
Conference
2012
2011
A comparison of the acute toxicity profile between two-dimensional and three-dimensional image-guided radiotherapy for postoperative prostate cancer
Piet Ost
Werner De Gersem
BRUNO DE POTTER
Valérie Fonteyne
Wilfried De Neve
Gert De Meerleer
A1
Journal Article
in
CLINICAL ONCOLOGY
2011
A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer
Piet Ost
BART DE TROYER
Valérie Fonteyne
Willem Oosterlinck
Gert De Meerleer
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2011
Analysis of prostate bed motion using daily cone-beam computed tomography during postprostatectomy radiotherapy
Piet Ost
Gert De Meerleer
Werner De Gersem
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2011
Delineation of the postprostatectomy prostate bed using computed tomography: interobserver variability following the EORTC delineation guidelines
Piet Ost
Gert De Meerleer
Tom Vercauteren
Werner De Gersem
Liv Veldeman
Katrien Vandecasteele
Valérie Fonteyne
Geert Villeirs
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2011
High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for resing or persisting prostate specific antigen : 5-year results
Piet Ost
Nicolaas Lumen
An-Sofie Goessaert
Valérie Fonteyne
BART DE TROYER
Filip Jacobs
Gert De Meerleer
A1
Journal Article
in
EUROPEAN UROLOGY
2011
Intensity-modulated radiotherapy: the gold standard for postprostatectomy irradiation?
Alberto Bossi
Gert De Meerleer
Piet Ost
Editorial material
2011
Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study
Piet Ost
Bruno Speleers
Gert De Meerleer
Wilfried De Neve
Valérie Fonteyne
Geert Villeirs
Werner De Gersem
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2011
Whole abdominopelvic radiotherapy using intensity-modulated arc therapy in the palliative treatment of chemotherapy-resistant ovarian cancer with bulky peritoneal disease: a single-institution experience
Gert De Meerleer
Katrien Vandecasteele
Piet Ost
Louke Delrue
Hannelore Denys
Amin Makar
Bruno Speleers
Simon Van Belle
Rudy Van den Broecke
Valérie Fonteyne
et al.
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2011
2010
Re: Michael L. Eisenberg, Benjamin J. Davies, Matthew R. Cooperbert, et al. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol 2010;57:622-30
Piet Ost
Alberto Bossi
Gert De Meerleer
A2
Journal Article
in
EUROPEAN UROLOGY
2010
2009
Adjuvant High-Dose Intensity-Modulated Radiotherapy after Radical Prostatectomy for Prostate Cancer: Clinical Results in 104 Patients
Piet Ost
Valérie Fonteyne
Geert Villeirs
Nicolaas Lumen
Willem Oosterlinck
Gert De Meerleer
A1
Journal Article
in
EUROPEAN UROLOGY
2009
Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001)
Piet Ost
Valérie Fonteyne
Wilfried De Neve
Werner De Gersem
Carlos De Wagter
Katrien Vandecasteele
Fréderic Duprez
Gert De Meerleer
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2009
2008
F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma - A case report
Piet Ost
Sylvie Rottey
Peter Smeets
Tom Boterberg
Barbara Stragier
Ingeborg Goethals
A1
Journal Article
in
Journal of Thoracic Imaging
2008
Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy
Gert De Meerleer
Valérie Fonteyne
SABINE MEERSSCHOUT
Caroline Van den Broecke
Geert Villeirs
Nicolaas Lumen
Piet Ost
Katrien Vandecasteele
Wilfried De Neve
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2008
2005
Postoperative intensity-modulated radiotherapy in sinonasal carcinoma - Clinical results in 39 patients
WIM DUTHOY
Tom Boterberg
F CLAUS
Piet Ost
Luc Vakaet
S BRAL
Fréderic Duprez
M VAN LANDUYT
Hubert Vermeersch
Wilfried De Neve
A1
Journal Article
in
CANCER
2005
2002
Postoperative radiotherapy for adenocarcinoma of the ethmoid sinuses: Treatment results for 47 patients
F CLAUS
Tom Boterberg
Piet Ost
JEROEN HUYS
Hubert Vermeersch
SABINE BRAEMS
Katrien Bonte
Mieke MOERMAN
Christoph VERHOYE
Wilfried De Neve
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2002
Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome?
Filip Claus
Tom Boterberg
Piet Ost
Wilfried De Neve
A1
Journal Article
in
Radiotherapy and Oncology
2002